Pharmaceutical

AstraZeneca announces GLP-1 combo to treat obesity and ...

AstraZeneca has announced its strategy for the cardiometabolic market, in parti...

ProKidney amends Phase III protocol in light of Phase I...

The Phase II interim data shows ProKidney’s autologous cell therapy React (...

Reform in South Korea means progression in improving ti...

South Korea has been busy with a series of reforms that aim to accelerate the t...

Analytical testing: Ten questions that accelerate drug ...

The pharmaceutical industry is already highly competitive. It's a business driv...

Teva and Royalty Pharma to expedite olanzapine LAI rese...

Teva Pharmaceuticals has entered a partnership with Royalty Pharma to expedite ...

Novartis signs agreement for Legend Biotech’s CAR-T the...

Novartis Pharma has signed an exclusive worldwide licence agreement for Leg...

Orphelia pushes boundaries with regulatory barriers for...

Orphelia Pharma is taking action to drive regulatory agencies like the European...

Telix plans $125m acquisition of radiopharmaceuticals c...

Telix Pharmaceuticals has signed a conditional non-binding term sheet to acquir...

AMA urges coverage of obesity treatments as payers balk...

The American Medical Association Monday called on insurance companies, employers...

Study suggests Covid rebound is far more common with Pa...

A small and preliminary study published Monday seems to indicate that patients r...

Opinion: Ohio has enshrined the right to an abortion. B...

Ohio has enshrined the right to an abortion. But major obstacles remain for pati...

Life expectancy for men in U.S. falls to 73 years — six...

American men's life expectancy is now 73.2 years, compared with women's 79.1. Wh...

Is there a bigger move being planned at Cigna?

An analyst has questions about Cigna's potential efforts to sell its Medicare Ad...

STAT+: Michigan bill that would pare back pharma liabil...

A one-of-a-kind law in Michigan that prevents the state government and residents...

These are the need-to-know biotech stories from this we...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Former MIT biologist, who lost positions after e...

Former MIT star biologist David Sabatini, who lost his position after he was acc...